Skip to main content
. Author manuscript; available in PMC: 2021 Jun 11.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2016 Mar 21;43(10):1784–1791. doi: 10.1007/s00259-016-3357-x

Table 3.

Lesion detection rates for 68Ga-DOTATATE, 18F-FDG, 18F-FDOPA and 18F-FDA PET/CT, and CT/MRI

Lesion location 68Ga-DOTATATE PET/CT
 18F-FDG PET/CT
 18F-FDOPA PET/CT
 18F-FDA PET/CT
 CT/MRI
Detection
rate (%)		 95 %
CI (%)		 Detection
rate (%)		 95 %
CI (%)		 Detection
rate (%)		 95 %
CI (%)		 Detection
rate (%)		 95 %
CI (%)		 Detection
rate (%)		 95 %
CI (%)
All compartments 97.6 95.8 – 98.7 49.2 44.5 – 53.6 74.8 69.0 – 79.9 77.7 71.5 – 82.8 81.6 77.8 – 84.8
Mediastinum 100 92.3 – 100 56.5 42.3 – 69.8 70.8 50.8 – 85.1 100 84.5 – 100 58.7 44.3 – 71.7
Lungs 94.7 95.1 – 97.1 55.3 45.3 – 65.0 98.1 90.1 – 99.7 68.4 52.5 – 80.9 94.7 88.2 – 97.7
Abdomen 100 95.1 – 100 56.8 45.3.4 – 67.4 73.2 58.1 – 84.3 92.1 79.2 – 97.3 77.0 66.3 – 85.1
Liver 87.5 75.3 – 94.1 12.5 5.9 – 24.7 84.5 57.8 – 95.7 69.2 42.4 – 87.3 93.8 83.2 – 97.8
Bone 100 98.1 – 100 50.3 43.4 – 57.1 64.0 54.7 – 72.3 71.2 62.2 – 79.9 79.4 73.3 – 84.4